For decades, taking low-dose aspirin every day was widely recommended as an easy way to prevent heart attacks and strokes. But that advice has changed.
People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...
Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...
Scientists at UMass Amherst and Ernest Pharmaceuticals developed BacID, a bacterial cancer therapy activated by aspirin. This ...
nevertheless, there was a small but statistically significant increase in major GI bleeding (47 [0.4%] vs 29 [0.2%]; p = 0.04) with high-dose versus low-dose aspirin.
A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver ...
Expected to begin in 2027, the trials will involve human patients, and the researchers are working to obtain the necessary ...
Among patients taking aspirin, the use of 12 weeks of famotidine ... prostaglandin analogues, warfarin, high-dose steroids, cytotoxic drugs, nonsteroidal anti-inflammatory drugs, or bisphosphonates ...